Gilead Sciences (GILD) Consolidated Net Income (2009 - 2026)
Gilead Sciences (GILD) recorded Consolidated Net Income of -$10.5 billion in Q2 2026, compared with $1.96 billion a year earlier.
Powered by 
Analysis
Gilead Sciences (GILD) Consolidated Net Income (2009 - 2026) Analysis & Trends
On a TTM basis, Gilead Sciences' Consolidated Net Income came in at -$3.24 billion as of Jun 30, 2026; for FY2025, it was $8.51 billion.
- Annual Consolidated Net Income has a five-year compound annual growth rate of 148.9% (FY2020 to FY2025).
- Across earlier years, Consolidated Net Income came in at $480 million in FY2024 (-91.4%), $5.61 billion in FY2023 (+22.9%), $4.57 billion in FY2022 (-26.4%) and $6.2 billion in FY2021.
- The Q2 2026 figure is the lowest quarterly Consolidated Net Income in data going back to Q1 2009.
- On a year-over-year basis, Consolidated Net Income rose in five of the last six quarters, with growth averaging 37.4%.
- Peak year-over-year performance for Consolidated Net Income in the last five years was growth of 632.6% in Q3 2021, against a decline of 99.3% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.02 billion (Q1 2026), $2.18 billion (Q4 2025) and $3.05 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.50 Bn |
| Mar 31, 2026 | 2.02 Bn |
| Dec 31, 2025 | 2.18 Bn |
| Sep 30, 2025 | 3.05 Bn |
| Jun 30, 2025 | 1.96 Bn |
| Mar 31, 2025 | 1.32 Bn |
| Dec 31, 2024 | 1.78 Bn |
| Sep 30, 2024 | 1.25 Bn |
| Jun 30, 2024 | 1.61 Bn |
| Mar 31, 2024 | -4.17 Bn |
| Dec 31, 2023 | 1.42 Bn |
| Sep 30, 2023 | 2.17 Bn |
| Jun 30, 2023 | 1.04 Bn |
| Mar 31, 2023 | 985.00 Mn |
| Dec 31, 2022 | 1.63 Bn |
| Sep 30, 2022 | 1.79 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 12.00 Mn |
| Dec 31, 2021 | 376.00 Mn |
| Sep 30, 2021 | 2.59 Bn |
API Access
Gilead Sciences Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();